Purines as neurotransmitters and neuromodulators in blood vessels

Current Vascular Pharmacology

Volumn 7, Issue 1, 2009, Pages 3-14

  Ralevic, Vera ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adenosine 5' triphosphate (ATP); Neurotransmission; Noradrenaline; P2 receptors; Perivascular nerves; Purines; Sensory nerves; Sympathetic nerves

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ALPHA ADRENERGIC RECEPTOR; NEUROPEPTIDE Y; NEUROTRANSMITTER; NORADRENALIN; NUCLEOTIDASE; PURINE DERIVATIVE; PURINERGIC P2 RECEPTOR; PURINERGIC P2X RECEPTOR;

AGE DISTRIBUTION; BLOOD VESSEL; BLOOD VESSEL INNERVATION; BLOOD VESSEL TONE; ENDOTHELIUM; ERYTHROCYTE; HUMAN; NEUROMODULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; REVIEW; SMOOTH MUSCLE CONTRACTION; SPECIES DIFFERENCE; SYMPATHETIC NERVE; THROMBOCYTE; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD PRESSURE; METABOLISM; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD PRESSURE; HUMANS; NEUROPEPTIDE Y; NOREPINEPHRINE; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2;

EID: 61549088501     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016109787354123     Document Type: Review

References (168)

1. Burnstock G. Historical Review: ATP as a neurotransmitter. Trends Pharmacol Sci 2006; 27: 166-76.
2. Burnstock G. Physiology and pathophysiogy of purinergic neurotransmission. Physiol Rev 2007; 87: 659-797.
3. 2Y purinoceptors? Pharmacol Ther 1994; 64: 445-75.
4. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-92.
5. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, et al.; International Union of Pharmacology. Update and subclassification of the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006; 58: 281-341.
6. Pakdeechote P, Rummery NM, Ralevic V, Dunn WR. Raised tone reveals purinergic-mediated responses to sympathetic nerve stimulation in the rat perfused mesenteric vascular bed. Eur J Pharmacol 2007; 563: 180-6.
7. Rummery NM, Brock JA, Pakdeechote P, Ralevic V, Dunn WR. ATP is the predominant sympathetic neurotransmitter in rat mesenteric arteries at high pressure. J Physiol 2007; 582.2: 745-754.
8. Yoshioka K, Saitoh O, Nakata H. Heteromeric association creates a P2Y-like adenosine receptor. PNAS 2001; 98: 7617-22.
9. 1 receptors in living cells. FEBS Lett 2002; 523: 147-51.
10. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002; 82: 1013-67.
11. Alexander SPH, Mathie A, Peters JA. Guide to Receptors and Channels, 2nd Edition. Br J Pharmacol 2006; 147: S1-83.
12. Von Kügelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 2006; 110: 415-32.
13. Burnstock G. Co-Transmission. The Fifth Heymans Memorial Lecture. Arch Int Pharmacodyn Ther 1990; 304: 7-33.
14. Burnstock G, Kennedy C. Purinergic receptors in the cardiovascular system. Prog Pharmacol 1986; 6: 111-32.
15. Lundberg JM. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adesnosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 1996; 48: 113-78.
16. Kirkpatrick K, Burnstock G. Sympathetic nerve-mediated release of ATP from the guinea-pig vas deferens is unaffected by reserpine. Eur J Pharmacol 1987; 138: 207-14.
17. Sneddon P, Burnstock G. ATP as a co-transmitter in rat tail artery. Eur J Pharmacol 1984; 106: 149-52.
18. Thapaliya S, Matsuyama H, Takewaki T. ATP released from perivascular nerves hyperpolarises smooth muscle cells by releasing an endothelium-derived factor in hamster mesenteric arteries. J Physiol 1999; 521: 191-9.
19. Burnstock G, Warland JJI. A pharmacological study of the rabbit saphenous vein in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation. Br J Pharmacol 1987; 90: 111-120.
20. Racchi H, Irarrazabal MJ, Howard M, Moran S, Zalaquett R, Huidobro-Toro JP. Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein. Br J Pharmacol 1999; 126: 1175-85.
21. Stephens N, Bund SJ, Faragher EB, Heagerty AM. Neurotransmission in human resistance arteries: contribution of alpha 1- and alpha 2-adrenoceptors but not P2-purinoceptors. J Vasc Res 1992; 29: 347-52.
22. Sjoblom-Widfeldt N, Gustafsson N, Nilsson H. Sympathetic transmission in small mesenteric arteries from the rat: influence of impulse pattern. Acta Physiol Scand 1990; 138: 523-8.
23. Yamamoto R, Takasaki K, Nickols GA. Purinergic vasoconstrictor component revealed by moderate cooling in the isolated mesenteric vasculature of Sprague-Dawley rats. J Pharmacol Exp Ther 1992; 262: 1133-8.
24. Gitterman DP, Evans RJ. Nerve evoked P2X receptor contractions of rat mesenteric arteries; dependence on vessel size and lack of L-type calcium channels and calcium-induced calcium release. Br J Pharmacol 2001; 132: 1202-8.
25. Ramme D, Regenold JT, Starke K, Busse R, Illes P. Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery. Naunyn Schmied Arch Pharmacol 1987; 336: 267-73.
26. Evans RJ, Surprenant A. Vasoconstricition of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP. Br J Pharmacol 1992; 106: 242-9.
27. Ellis JL, Burnstock G. Modulation of neurotransmission in the guinea-pig vas deferens by capsaicin: involvement of calcitonin gene-related peptide and substance P. Br J Pharmacol 1989; 98: 707-13.
28. Von Kügelgen I, Starke K. Release of noradrenaline and ATP by electrical stimulation and nicotine in guinea-pig vas deferens. Naunyn Schmiedebergs Arch Pharmacol 1991; 344: 419-29.
29. Driessen B, von Kugelgen I, Starke K. P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guine-pig vas deferens. Naunyn Schmiedeberg's Arch Pharmacol 1994; 350: 42-8.
30. Todorov LD, Mihaylova-Todorova S, Craviso GL, Bjur RA, Westfall DP. Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens. J Physiol 1996; 496: 731-48.
31. Dunn WR, Brock JK, Hardy TA. Electrochemical and electrophysiological characterization of neurotransmitter release from sympathetic nerves supplying rat mesenteric arteries. Br J Pharmacol 1999; 128: 174-80.
32. 2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur J Pharmacol 1985; 107: 161-8.
33. Kennedy C, Burnstock G. ATP causes postjunctional potentiation of noradrenergic contractions in the portal vein of guinea pig and rat. J Pharm Pharmacol 1986; 38: 307-9.
34. Ralevic V, Burnstock G. Postjunctional synergism of noradrenaline and adenosine 5'-triphosphate in the mesenteric arterial bed of the rat. Eur J Pharmacol 1990; 175: 291-9.
35. Zimmerman H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev Res 2001; 52: 44-56.
36. Holton P. The liberation of ATP on antidromic stimulation of sensory nerves. J Physiol (Lond) 1959; 145: 494-504.
37. Simonsen U, Garcia-Sacristan A, Prieto D. Involvement of ATP in the non-adrenergic non-cholinergic inhibitory neurotransmission of lamb isolated coronary small arteries. Br J Pharmacol 1997; 120: 411-20.
38. Draid M, Shiina T, El-Mahmoudy A, Boudaka A, Shimizu Y, Takewaki T. Neurally released ATP mediates endothelium-dependent hyperpolarization in the circular smooth muscle cells of chicken anterior mesenteric artery. Br J Pharmacol 2005; 146: 983-989.
39. Liu SF, Crawley DE, Evans TW, Barnes PJ. Endothelium-dependent nonadrenergic, non-cholinergic neural relaxation in guinea pig pulmonary artery. J Pharmacol Exp Ther 1992; 260: 541-8.
40. Brizzolara AL, Crowe R, Burnstock G. Evidence for the involvement of both ATP and nitric oxide in non-adrenergic non-cholinergic inhibitory neurotransmission in the rabbit portal vein. Br J Pharmacol 1993; 109: 606-8.
41. Inoue T, Kannan MS. Nonadrenergic and noncholinergic excitatory neurotransmission in rat intrapulmonary artery. Am J Physiol Heart Circ Physiol 1988; 254: H1142-8.
42. Ishizaki M, Iizuka Y, Suzuki-Kusaba M, Kimura T, Satoh S. Nonadrenergic contractile response of guinea pig portal vein to electrical field stimulation mimics response to UTP but not to ATP. J Cardiovasc Pharmacol 1997; 29: 360-6.
43. Sperlágh B, Heinrich A, Csölle C. P2 receptor-mediated modulation of neurotransmitter release - an update. Purinergic Signalling 2007; 3: 269-84.
44. Brown CM, Collis MG. Adenosine A1 receptor mediated inhibition of nerve stimulation induced contractions of the rabbit portal vein. Eur J Pharmacol 1983; 93: 277-82.
45. Illes P, Jackisch R, Regenold JT. Presynaptic P1-purinoceptors in jejunal branches of the mesenteric artery and their possible function. J Physiol 1988; 397: 13-29.
46. Todorov LD, Mihaylova TS, Westfall TD, Sneddon P, Kennedy C, Bjur RA, et al. Neuronal release of soluble nucleotidases and their role neurotransmitter inactivation. Nature 1997; 387: 76-9
47. Rubino A, Ralevic V, Burnstock G. The P1-purinoceptors that mediate the prejunctional inhibitory effect of adenosine on capsaicin-sensitive nonadrenergic noncholinergic neurotransmission in the rat mesenteric arterial bed are of the A1 subtype. J Pharmacol Exp Ther 1993; 267: 1100-4.
48. 1 subtype. Naunyn-Schmiedeberg's Arch Pharmacol 1991; 344: 464-70.
49. Kawasaki H, Nuki C, Saito A, Takasaki K. Adrenergic modulation of calcitonin gene-related peptide (CGRP)-containing nerve-mediated vasodilation in the rat mesenteric resistance vessel. Brain Res 1990; 506: 287-90.
50. Kawasaki H, Chikako N, Saito A, Takasaki K. NPY modulates neurotransmission of CGRP-containing nerves in rat mesenteric arteries. Am J Physiol 1991; 261: H683-90.
51. 2-receptor modulation of noradrenergic neurotransmission in rat kidney. Br J Pharmacol 1997; 121: 1255-62.
52. 2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn Schmiedeberg's Arch Pharmacol 1989; 340: 522-32.
53. 2-purinoceptors in feedback control of sympathetic neurotransmitter release. Neuroscience 1993; 56: 263-7.
54. 2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens. Naunyn-Schmied Arch Pharmacol 1994; 349: 125-34.
55. 2Y-like purinoceptors. Naunyn-Schmied Arch Pharmacol 1993; 348: 352-7.
56. 2-purinoceptors. Br J Pharmacol 1993; 110: 1465-72.
57. Morikawa T, Tanaka N, Kubota Y, Mizuno H, Nakamura K, Kunitomo M, et al. ATP modulates the release of noradrenaline through two different prejunctional receptors on the adrenergic nerves of rat prostate. Clin Exp Pharmacol Physiol 2007; 34: 601-5.
58. 2-purinoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 352: 17-24.
59. Miyahara H, Suzuki H. Pre- and postjunctional effects of adenosine triphosphate on noradrenergic transmission in the rabbit ear artery. J Physiol 1987; 389: 423-40.
60. 3H]-noradrenaline release from the isolated guine-pig right atrium by P2X-receptors located on axon terminals. Br J Pharmacol 2000; 131: 1775-83.
61. Boehm S. ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors. J Neurosci 1999; 19: 737-46.
62. von Kügelgen I, Nörenberg W, Illes P, Schobert A, Starke K. Differences in the mode of stimulation of cultured rat sympathetic neurones between ATP and UTP. Neuroscience 1997; 78: 935-41.
63. von Kügelgen I, Nörenberg W, Meyer A, Illes P, Starke K. Role of action potentials and calcium influx in ATP- and UDP-induced noradrenaline release from rat cultured sympathetic neurones. Naunyn Schmiedeberg's Arch Pharmacol 1999; 359: 360-9.
64. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 1996; 16: 2495-507.
65. 6 and atypical UTP-sensitive receptors coupled to rises in intracellular calcium in mouse cultured superior cervical ganglion neurons and glia. Br J Pharmacol 2004; 143: 525-32.
66. 1 receptors revealed using knockout mice. Mol Pharmacol 2004; 65: 139-48.
67. Koganezawa T, Ishikawa T, Fujita Y, Yamashita T, Tajima T, Honda M, et al. Local regulation of skin blood flow during cooling involving presynaptic P2 purinoceptors in rats. Br J Pharmacol 2006; 148: 579-86.
68. Burnstock G. P2X receptors in sensory neurons. Br J Anaesth 2000; 84: 476-88.
69. 2B adenosine and P2X purinergic receptors. Neuroscience 2002; 110: 123-9.
70. Ralevic V. Mechanism of prolonged vasorelaxation to ATP in the rat isolated mesenteric arterial bed. Br J Pharmacol 2001; 132: 685-92.
71. Rubino A, Amerini S, Ledda F, Mantelli L. ATP modulates the efferent function of capsaicin-sensitive neurones in the guinea-pig isolated atria. Br J Pharmacol 1992; 105: 516-20.
72. 2Y- and facilitatory A2A-purinoceptors. Br J Pharmacol 1996; 117: 156-60.
73. 2A-adenosine receptor-mediated facilitation of noardrenaline release in isolated rat tail artery. Br J Pharmacol 2002; 136: 230-6.
74. Dunn PM, Zhong Y, Burnstock G. P2X receptors in peripheral neurones. Prog Neurobiol 2001; 65: 107-34.
75. Spyer KM, St Lambert JH, Thomas T. Central nervous system control of cardiovascular function: neural mechanisms and novel modulators. Clin Exp Pharmacol Physiol 1997; 24: 743-7.
76. Ralevic V. P2 receptors in the central and peripheral nervous systems modulating sympathetic vasomotor tone. J Auton Nerv Syst 2000; 81: 205-11.
77. Milner P, Bodin P, Loesch A, Burnstock G. Endothelin and ATP but not vasopressin are released from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun 1990; 170: 649-56.
78. Milner P, Kirkpatrick KA, Ralevic V, Toothill VJ, Pearson JD, Burnstock G. Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow. Proc Roy Soc Series B 1990; 241: 245-8.
79. Ralevic V, Milner P, Kirkpatrick KA, Burnstock G. Flow-induced release of adenosine 5'-triphosphate from endothelial cells of rat mesenteric arterial bed. Experientia 1991; 48: 31-4.
80. Bodin P, Milner P, Winter R, Burnstock G. Chronic hypoxia changes the ratio of endothelin to ATP release from rat aortic endothelial cells exposed to high flow. Proc R Soc Lond B 1992; 247: 131-5.
81. Saiag B, Bodin P, Shacoori V, Catheline M, Rault B, Burnstock G. Uptake and flow-induced release of uridine nucleotides from isolated vascular endothelial cells. Endothelium 1995; 2: 279-85.
82. Yang S, Cheek DJ, Westfall DP, Buxton IL. Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res 1994; 74: 401-7.
83. Buxton ILO, Kaiser RA, Oxhorn BC, Cheek DJ. Evidence supporting the nucleotide axis hypothesis: ATP release and metabolism by coronary endothelium. Am J Physiol 2001; 281: H1657-66.
84. Yegutkin G, Bodin P, Burnstock G. Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5'-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 2000; 129: 921-6.
85. Sedaa KO, Bjur RA, Shinozuka K, Westfall DP. Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta. J Pharmacol Exp Ther 1990; 252: 1060-7.
86. Von Kügelgen I, Starke K. Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci 1991; 12: 319-24.
87. Katsuragi T, Tokunaga T, Ogawa S, Soejima O, Sato C, Furukawa T. Existence of ATP-evoked ATP release system in smooth muscles. J Pharmacol Exp Ther 1991; 259: 513-8.
88. Bergfeld GR, Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 1992; 26: 40-7.
89. Ellsworth ML, Forrester T, Ellis CG, Dietrich HH. The erythrocyte as a regulator of vascular tone. Am. J Physiol 1995; 269: H2155-61.
90. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol 1996; 271: H2717-22.
91. Goetz V, Da Prada M, Pletscher A. Adenine-, guanine- and uridine- 5'-phosphonucleotides in blood platelets and storage organelles of various species. J Pharmacol Exp Ther 1971; 178: 210-5.
92. Born GVR, Kratzer MAA. Source and concentration of extracellular adenosine triphosphate during hemostasis in rats, rabbits and man. J Physiol 1984; 354: 419-29.
93. Lewis CJ, Evans RJ. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterisation of the properties of mesenteric artery P2X receptor ion channels. Br J Pharmacol 2000; 131: 1659-66.
94. Yeung D, Kharidia R, Brown SC, Gorecki DC. Enhanced expression of the P2X4 receptor in Duchenne muscular dystrophy correlates with macrophage invasion. Neurobiol Dis 2004; 15: 212-20.
95. Metcalfe MJ, Baker DM, Turmaine M, Burnstock G. Alterations in purinoceptor expression in human long sapehnous vein during varicose disease. Eur J Vasc Endovasc Surg 2007; 33: 239-50.
96. Bo X, Karoon P, Nori SL, Bardini M, Burnstock G. P2X purinoceptors in post-mortem human cerebral arteries. J Cardiovasc Pharmacol 1998; 31: 794-9.
97. Bo X, Sexton A, Xiang Z, Nori SL, Burnstock G. Pharmacological and histochemical evidence for P2X receptors in human umbilical vessels. Eur J Pharmacol 1998; 353: 59-65.
98. Lewis CJ, Evans RJ. P2X receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J Vasc Res 2001; 38: 332-40.
99. 5 receptor subunits reveals a novel ATP-gated ion channel. Mol Pharmacol 1998; 54: 989-93.
100. 1 knockout mice. Acta Physiol Scand 2004; 181: 445-53.
101. 1 receptors on smooth muscle cells of the mouse vas deferens. Synapse 2001; 42: 1-11.
102. 1-receptor clusters on smooth muscle cells I relation to nerve varicosities in the rat urinary bladder. J Neurocytol 1998; 27: 529-39.
103. Barden JA, Cottee LJ, Bennett MR. Vesicle-associated proteins and P2X receptor clusters at single sympathetic varicosities in mouse vas deferens. J Neurocytol 1999; 28: 469-80.
104. Rayment SJ, Ralevic V, Barrett DA, Cordell R, Alexander SPH. A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release. FASEB J 2006; 21: 577-85.
105. Rayment SJ, Latif ML, Ralevic V, Alexander SPH. Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in procine isolated arteries. Br J Pharmacol 2007; 150: 604-12.
106. Lewis CJ, Ennion SJ, Evans RJ. P2 purinoceptor-mediated control of rat cerebral (pial) microvasculature; contribution of P2X and P2Y receptors. J Physiol 2000; 527: 315-24.
107. Malmsjö M, Adner M, Harden K, Pendergast W, Edvinsson L, Erlinge D. The stable pyrimidines UDPβS and UTPγS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br J Pharmacol 2000; 131: 51-6.
108. Malmsjö M, Hou M, Harden K, Pendergast W, Pantev E, Edvinsson L, et al. Characterisation of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate. J Pharmacol Exp Ther 2000; 293: 755-60.
109. Malmsjö M, Hou M, Pendergast W, Erlinge D, Edvinsson L. The stable pyrimidines UDPβS and UTPγS discriminate between contractile cerebrovascular P2 receptors. Eur J Pharmacol 2003; 458: 305-11.
110. 2 purinoceptor, in rabbit ear artery. Naunyn-Schmiedeberg's Arch Pharmacol 1987; 336: 556-60.
111. 2x purinoceptors. Blood Vessels 1990; 27: 352-64.
112. 2x purinoceptors are present on the vascular smooth muscle and respectively mediate the UTP- and ATP-induced contractions of the dog maxilliary internal vein. Res Commun Chem Pathol Pharmacol 1992; 76: 89-94.
113. Ralevic V, Burnstock G. Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ Res 1991; 69: 1583-90.
114. i, membrane potential and force in isolated rat small arteries. J Vasc Res 1992; 29: 385-95.
115. 2X-purinoceptors. Br J Pharmacol 1994; 113: 1015-21.
116. Lagaud GJL, Stoclet JC, Andriantsitohaina R. Calcium handling and purinoceptor subtypes involved in ATP-induced contraction in rat small mesenteric arteries. J Physiol 1996; 492: 689-703.
117. Brizzolara A, Burnstock G. Endothelium-dependent and endothelium-independent vasodilatation of the hepatic artery of the rabbit. Br J Pharmacol 1991; 103: 1206-12.
118. Mathieson JJI, Burnstock G. Purine-mediated relaxation and constriction of isolated rabbit mesenteric artery are not endothelium-dependent. Eur J Pharmacol 1985; 118: 221-9.
119. 2-purinoceptor in the longitudinal muscle of the rabbit portal vein. Eur J Pharmacol 1985; 111: 49-56.
120. 2 receptors in rabbit pulmonary artery. Br J Pharmacol 1997; 120: 553-8.
121. 2-purinoceptor subtypes in human small pulmonary arteries. Br J Pharmacol 1989; 98: 1014-20.
122. Keefe KD, Pasco JS, Eckman DM. Purinergic relaxation and hyperpolarization in guinea pig and rabbit coronary artery: role of the endothelium. J Pharmacol Exp Ther 1992; 260: 592-600.
123. 2-purinoceptor subtypes on the smooth muscle and endothelium of rabbit coronary artery. J Cardiovasc Pharmacol 1994; 23: 709-15.
124. 2B receptors in human skeletal muscle. Acta Physiol Scand 2000; 169: 283-90.
125. 1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels. J Pharmacol Exp Ther 1992; 260: 437-43.
126. 2 receptors in guinea-pig aorta. Eur J Pharmacol 1990; 190: 329-35.
127. Szentmiklosi AJ, Ujfalusi A, Cseppento A, Nosztray K, Kovacs P, Szabo JZ. Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary artery of guinea pigs. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 351: 417-25.
128. 2 receptor mediated coronary vasodilatation in the dog. Cardiovasc Res 1994; 28: 906-11.
129. Ray FR, Huang W, Slater M, Barden JA. Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts. Atherosclerosis 2002; 162: 55-61.
130. Wang L, Andersson M, Karlsson L, Watson M-A, Cousens DJ, Jern S, et al. Increased mitogenic and decreased contractile P2 receptors in smooth muscle cells by shear stress in human blood vessels with intact endothelium. Arterioscler Thromb Vasc Biol 2003; 23: 1370-6.
131. Yang S, Buxton ILO, Probert CB, Talbot JN, Bradley ME. Evidence for a discrete UTP receptor in cardiac endothelial cells. Br J Pharmacol 1996; 117: 1572-8.
132. Hansen MA, Dutton JL, Balcar VJ, Barden JA, Bennett MR. P2X (purinergic) receptor distributions in rat blood vessels. J Auton Nerv Syst 1999; 75: 147-55.
133. 2 receptor immunoreactivity in vascular endothelial cells in rat brain. Endothelium 2000; 7: 93-8.
134. Glass R, Burnstock G. Immunohistochemical identification of cells expressing ATP-gated cation channels (P2X receptors) in the adult rat thyroid. J Anat 2001; 198: 569-79.
135. Schwiebert LM, Rice WC, Kudlow BA, Taylor AL, Schwiebert EM. Extracellular ATP signalling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. Am J Physiol Cell Physiol 2002; 282: C289-301.
136. 4 purinoceptors. Circ Res 2000; 87: 385-91.
137. 4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol Heart Circ Physiol 2000; 279: H285-92.
138. 4 receptor gene transcription in endothelial cells exposed to shear stress. Am. J. Physiol 2001; 280: H2214. 21.
139. 4-deficient mice. Nat Med 2006; 12: 133-7.
140. 6 receptors associated with VE-cadherin in human endothelial cells. Cell Mol Life Sci 2002; 59: 870-81.
141. 2B receptors in human skeletal muscle. Acta Physiol Scand 2000; 169: 283-90.
142. Westfall TC, Meldrum MJ. Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension. Ann Rev Pharmacol Toxicol 1985; 25: 621-41.
143. Dhital KK, Gerli R, Lincoln J, Milner P, Tanganelli P, Weber G, et al. Increased density of perivascular nerves to the major cerebral vessels of the spontaneously hypertensive rat: differential changes in noradrenaline and neuropeptide Y during development. Brain Res 1988; 444: 33-45.
144. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988; 11: 3-20.
145. Head RJ. Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels 1989; 26: 1-20.
146. Mangiarua EI, Lee RMKW. Increased sympathetic innervation in the cerebral and mesenteric arteries of hypertensive rats. Can J Physiol Pharmacol 1989; 68: 492-9.
147. Vidal M, Hicks PE, Langer SZ. Differential effects of α,β-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedeberg's Arch Pharmacol 1986; 332: 384-90.
148. Dalziel HH, Machaly M, Sneddon P. Comparison of the purinergic contribution to sympathetic vascular responses in SHR and WKY rats in vitro and in vivo. Eur J Pharmacol 1989; 173: 9-26.
149. Muir TC, Wardle KA. Vascular smooth muscle responses in normo- and hypertensive rats to sympathetic nerve stimulation and putative transmitters. J Auton Pharmacol 1989; 9: 23-34.
150. 2 inhibits noradrenaline release and purinergic pressor responses to renal nerve stimulation at 1Hz in isolated kidneys of young spontaneously hypertensive rats. J Hypertens 1990; 8: 897-908.
151. Vonend O, Okonek A, Stegbauer J, Habbel S, Quack I, Rump LC. Renovascular effects of sympathetic neurotransmitters ATP ad NPY are age-dependent in spontaneously hypertensive rats. Cardiovasc Res 2005; 66: 345-52.
152. Brock JA, Van Helden DF. Enhanced excitatory junction potentials in mesenteric arteries from spontaneously hypertensive rats. Pflugers Arch 1995; 430:901-8.
153. Kamikawa Y, Cline WH, Su C. Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats. Eur J Pharmacol 1980; 66: 347-53.
154. 3H]norepinephrine release from perfused mesenteric arteries of SHR and renal hypertensive rats. Eur J Pharmacol 1983; 87: 349-52.
155. 1-receptors in caudal arteries of spontaneously hypertensive rats. Eur J Pharmacol 1989; 174: 237-51.
156. Westfall TC, Han S-P, Kneupfer M, Martin J, Chen X, Del Valle K, et al. Neuropeptides in hypertension: role of neuropeptide Y and calcitonin gene-related peptide. Br J Clin Pharmacol 1990; 30: 75S-82S.
157. Kawasaki H, Saito A, Takasaki K. Age-related decrease of calcitonin gene-related peptide-containing vasodilator innervation in the mesenteric resistance vessel of the spontaneously hypertensive rat. Circ Res 1990; 67: 733-43.
158. Kawasaki H, Saito A, Takasaki K. Changes in calcitonin gene-related peptide (CGRP)-containing vasodilator nerve activity in hypertension. Brain Res 1990; 518: 303-7.
159. Lee RMKW, Nagahama M, McKenzie R, Daniel EE. Peptide-containing nerves around blood vessels of stroke-prone spontaneously hypertensive rats. Hypertension 1988; 11: 1117-20.
160. Takiguchi Y, Satoh N, Hashimoto H, Nakashima M. Changes in vascular reactivity in experimental diabetic rats: comparison with hypothyroid rats. Blood vessels 1988; 25: 250-60.
161. Hart JL, Freas W, McKenzie JE, Muldoon SM. Adrenergic nerve function and contractile activity of the caudal artery of the streptozotocin diabetic rat. J Auton Nerv Syst 1988; 25: 49-57.
162. Speirs L, Donnelly A, Lynch J, Scholfield N, Johnson C. ATP and norepinephrine contributions to sympathetic vasoconstriction of tail artery are altered in streptozotocin-diabetic rats. Am J Physiol Heart Circ Physiol 2006; 291: H2327-33.
163. Karanth SS, Springall DR, Francavilla S, Mirrlees DJ, Polak JM. Early increase in CGRP- and VIP-immunoreactive nerves in the skin of streptozotocin-induced diabetic rats. Histochemistry 1990; 94: 659-66.
164. Ralevic V, Belai A, Burnstock G. Impaired sensory-motor nerve function in the isolated mesenteric arterial bed of streptozotocin-diabetic and ganglioside-treated streptozotocin-diabetic rats. Br J Pharmacol 1993; 110: 1105-11.
165. Ziganshin AU, Khaziakhmetov DF, Ziganshina LE, Khaziakhmetova VN, Jourjikiya RK, Ziganshin BA, et al. Varicose disease affects the P2 receptor-mediated responses of human greater saphenous vein. Vas Pharmacol 2005; 42: 17-21.
166. Verbeuren TJ, Simonet S, Herman AG. Diet-induced atherosclerosis inhibits release of noradrenaline from sympathetic nerves in rabbit arteries. Eur J Pharmacol 1994; 270: 27-34.
167. Mione MC, Dhital KK, Amenta F, Burnstock G. An increase in the expression of neuropeptidergic vasodilator, but not vasoconstrictor, cerebrovascular nerves in aging rats. Brain Res 1988; 460: 103-13.
168. Li Y, Duckles SP. Effect of age on vascular content of calcitonin gene-related peptide and mesenteric nerve activity in the rat. Eur J Pharmacol 1993; 236: 373-78.